SEC Form 4 · accession 0001179110-18-014278

Care.com Inc · CRCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — General Counsel and Secretary

Period of report

Dec 24, 2018

Accepted (ET)

Dec 27, 2018 · 2:34 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001412270

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $0.001 par value	Dec 24, 2018	M	100	$6.70	A	26,925	D
Common Stock, $0.001 par value	Dec 24, 2018	S	100	$18.25	D	26,825	D
Common Stock, $0.001 par value	Dec 26, 2018	M	6,761	$6.70	A	33,586	D
Common Stock, $0.001 par value	Dec 26, 2018	M	8,750	$6.02	A	42,336	D
Common Stock, $0.001 par value	Dec 26, 2018	M	10,556	$12.01	A	52,892	D
Common Stock, $0.001 par value	Dec 26, 2018	M	3,733	$6.70	A	56,625	D
Common Stock, $0.001 par value^F2	Dec 26, 2018	S	29,800	$18.3982	D	26,825	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$6.70	Dec 24, 2018	M	100	D	—	Mar 9, 2026	Common Stock	100	66,740	D
Stock Option (Right to Buy)^F3	$6.70	Dec 26, 2018	M	6,761	D	—	Mar 9, 2026	Common Stock	6,761	59,979	D
Stock Option (Right to Buy)^F4	$6.02	Dec 26, 2018	M	8,750	D	—	Feb 28, 2023	Common Stock	8,750	0	D
Stock Option (Right to Buy)^F5	$12.01	Dec 26, 2018	M	10,556	D	—	Mar 15, 2027	Common Stock	10,556	16,691	D
Stock Option (Right to Buy)^F3	$6.70	Dec 26, 2018	M	3,733	D	—	Mar 9, 2026	Common Stock	3,733	56,246	D

F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 10, 2018.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.5950, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F3The underlying shares subject to the option vest and became exercisable in successive, equal quarterly installments over four years measured from March 9, 2016.
F4The underlying shares subject to the option vest and became exercisable in successive, equal quarterly installments over four years measured from February 1, 2013.
F5The underlying shares subject to the option vest and became exercisable in successive, equal quarterly installments over four years measured from March 9, 2017.